Covid-19: Sinovac booster dose can activate cellular immunity against Omicron variant, study suggests

  • Nation
  • Sunday, 02 Jan 2022

KUALA LUMPUR: Preliminary results of a study conducted by the Pontifical Catholic University in Chile (UC) shows that the Covid-19 Sinovac vaccine booster dose could activate cellular immunity against the Omicron variant on subjects who were given two doses of the same vaccine previously.

The objective of the study led by Millennium Institute on Immunology and Immunotherapy director Prof Dr Alexis M. Kalergis, was to assess whether the immunity activated by the Sinovac vaccine booster dose was able to recognise the Omicron variant.

Dr Alexis, in a statement released by Pharmaniaga Saturday (Jan 1), said those who have received the Covid-19 Sinovac vaccine booster dose had T-cell levels that were activated against the Omicron variant in a similar way to the original strain.

"This shows that the vaccine contains antigens that are found in the Omicron variant. The results show that when T-lymphocytes come in contact with the Omicron variant, they are able to produce gamma interferon which is capable of killing the dangerous virus,” he said.

Meanwhile, UC’s Academic and Scientific director for the CoronaVac Scientific-Clinical Study in Chile, Dr Susan Bueno, said it was most likely that partial recognition of these variants had contributed to the effectiveness of the vaccine among the population, despite the variants being widespread in Chile.

"Population data shows that the Covid-19 Sinovac vaccine has worked well so far to control the variants that have emerged,” she said.

The statement also said researchers in Chile in collaboration with the Catholic University, the University of Chile, the La Jolla Institute for Immunology in California (USA) and Sinovac in China were also in the midst of conducting a study on the antibody response against the new variant.

The new Omicron (B.1.1.529) Covid-19 variant of concern (VoC), identified in South Africa and also detected in Europe and Asia, has raised concerns worldwide given the number of mutations and reports that it might spread even faster and evade antibodies from prior infection of the virus or vaccination.

The Sinovac Covid-19 booster shot has recently been approved by the Drug Control Authority in Malaysia and is currently available in selected private healthcare facilities. - Bernama

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In Nation

Kit Siang has the ‘same rank’ as Nik Aziz, claims Dr M
MMEA detains fishing boat off Pulau Daya for employing illegal crewman
Social media users slam Dr M over ‘Penang owns Kedah’ issue
Revoke Dr M’s Tun-ship title, govt urged
Two killed in car-lorry crash in Sarawak
MACC probes report over allegations that Perikatan used gambling funds in election campaign
Pupils hurt by flying glass in van-bike collision in Seremban
Cops bust drug ring in Johor, seize RM160,000 worth of ganja and detain three
King, Queen see off Haj pilgrims, wish them safe journey
University student dies in Kuala Pilah accident

Others Also Read